Literature DB >> 33384915

The school-led Preventure study: Protocol of a cluster-randomised controlled trial of effectiveness to prevent adolescent alcohol misuse, internalising problems, and externalising problems through a personality-targeted intervention delivered by school staff.

Erin Veronica Kelly1, Lucinda Rachel Grummitt1, Louise Birrell1, Lexine Stapinski1, Emma Louise Barrett1, Julia Boyle1, Maree Teesson1, Nicola Clare Newton1.   

Abstract

Mental disorders and problematic alcohol use are common, co-occurring and cause significant harm to individuals and society. It is critical to intervene early to prevent chronic and debilitating trajectories. Existing prevention programs among adolescents are limited in effectiveness and implementation. This Australian-first study will examine the effectiveness and feasibility of a personality-targeted program called Preventure, in preventing the onset or escalation of alcohol use, internalising problems and externalising problems among young Australians, when delivered by school staff. A cluster randomised controlled trial (RCT) of effectiveness will be conducted from 2020 to 2022 with 12 schools in Sydney, Australia, with students aged 13 years at baseline. Schools will be randomly allocated to the Preventure intervention or a control condition who will receive their usual Health Education curriculum. Schools allocated to the intervention will deliver Preventure to students scoring one standard deviation above the population mean on one of four personality traits. Preventure consists of two 90-minute group sessions that incorporate cognitive-behavioural therapy and motivational interviewing to promote coping skills. Students will be invited to complete surveys at baseline, 6- and 12-months following the intervention. Primary outcomes include student alcohol use, internalising problems, and externalising problems. Implementation fidelity, feasibility and acceptability will also be examined through surveys with school staff and students. Ethical approval has been obtained from the University of Sydney Human Research Ethics Committee, and the State Education Research Applications Process for research in public schools in NSW. This trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12620000790943).
© 2020 The Author(s).

Entities:  

Keywords:  Alcohol use; Mental health; Personality; Prevention; Randomised controlled trial; Research translation; School

Year:  2020        PMID: 33384915      PMCID: PMC7772564          DOI: 10.1016/j.pmedr.2020.101286

Source DB:  PubMed          Journal:  Prev Med Rep        ISSN: 2211-3355


  54 in total

1.  The validity of the Substance Use Risk Profile Scale (SURPS) among Australian adolescents.

Authors:  Nicola C Newton; Emma L Barrett; Natalie Castellanos-Ryan; Erin Kelly; Katrina E Champion; Lexine Stapinski; Patricia J Conrod; Tim Slade; Natasha Nair; Maree Teesson
Journal:  Addict Behav       Date:  2015-09-25       Impact factor: 3.913

2.  Adapting the personality-targeted Preventure program to prevent substance use and associated harms among high-risk Australian adolescents.

Authors:  Emma L Barrett; Nicola C Newton; Maree Teesson; Tim Slade; Patricia J Conrod
Journal:  Early Interv Psychiatry       Date:  2013-11-26       Impact factor: 2.732

Review 3.  Trends in psychopathology across the adolescent years: what changes when children become adolescents, and when adolescents become adults?

Authors:  E Jane Costello; William Copeland; Adrian Angold
Journal:  J Child Psychol Psychiatry       Date:  2011-08-04       Impact factor: 8.982

4.  The Substance Use Risk Profile Scale: a scale measuring traits linked to reinforcement-specific substance use profiles.

Authors:  Patricia A Woicik; Sherry H Stewart; Robert O Pihl; Patricia J Conrod
Journal:  Addict Behav       Date:  2009-07-08       Impact factor: 3.913

5.  Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale.

Authors:  K M Connor; J R Davidson; L E Churchill; A Sherwood; E Foa; R H Weisler
Journal:  Br J Psychiatry       Date:  2000-04       Impact factor: 9.319

6.  Evaluating the differential effectiveness of social influence and personality-targeted alcohol prevention on mental health outcomes among high-risk youth: A novel cluster randomised controlled factorial design trial.

Authors:  Nicola C Newton; Lexine Stapinski; Maree Teesson; Tim Slade; Katrina E Champion; Emma L Barrett; Louise Birrell; Erin Kelly; Marius Mather; Patricia J Conrod
Journal:  Aust N Z J Psychiatry       Date:  2019-09-27       Impact factor: 5.744

7.  The long-term effectiveness of a selective, personality-targeted prevention program in reducing alcohol use and related harms: a cluster randomized controlled trial.

Authors:  Nicola C Newton; Patricia J Conrod; Tim Slade; Natacha Carragher; Katrina E Champion; Emma L Barrett; Erin V Kelly; Natasha K Nair; Lexine Stapinski; Maree Teesson
Journal:  J Child Psychol Psychiatry       Date:  2016-04-19       Impact factor: 8.982

8.  Adolescent health and wellbeing: a key to a sustainable future.

Authors:  Sabine Kleinert; Richard Horton
Journal:  Lancet       Date:  2016-05-09       Impact factor: 79.321

9.  Psychometric properties of the strengths and difficulties questionnaire.

Authors:  R Goodman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-11       Impact factor: 8.829

10.  The CAP study, evaluation of integrated universal and selective prevention strategies for youth alcohol misuse: study protocol of a cluster randomized controlled trial.

Authors:  Nicola C Newton; Maree Teesson; Emma L Barrett; Tim Slade; Patricia J Conrod
Journal:  BMC Psychiatry       Date:  2012-08-20       Impact factor: 3.630

View more
  1 in total

1.  The efficacy of a targeted PREVENTION programme for addictive behaviour (PREVENTURE) among vulnerable ADOlescents in France - study procotol.

Authors:  Morgane Guillou-Landreat; Elkhan Tahmazov; Schreck Benoit; Marie Grall-Bronnec; Patricia Conrod; Audrey Livet; Emmanuel Nowak; Jean -Yves Le Reste
Journal:  BMC Public Health       Date:  2021-04-23       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.